Stay updated on TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.

Latest updates to the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe footer now displays revision v3.8.0 instead of v3.7.2, while the study record remains inaccessible.SummaryDifference0.2%

- Check16 days agoChange DetectedA notice about NIH’s terminology transition appears above the ClinicalTrials.gov error page. It does not provide information about the study record.SummaryDifference1%

- Check23 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to show a 403 error.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page now displays a 403 Forbidden error and a Home option, replacing the study content and navigation with an error page that blocks access to the study record.SummaryDifference17%

- Check51 days agoChange DetectedThe page shows a new revision label: v3.7.0, replacing the previous v3.6.6. This indicates a minor update to the study record page rather than a change to the study data or visible content.SummaryDifference0.0%

Stay in the know with updates to TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.